Mathus-Vliegen et al., Dexfenfluramine in the treatment of severe ovesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour, 1992, J. of Int. Med., Vol. 232, pp. 119-127.* |
Mathus-Vliegen et al. Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight-loss, cardiovascular risk factors, food intake and eating behaviour, 1992, Journal of Internal Medicine, vol. 232 pp. 119-127.* |
Goodman and Gilman's Pharmacological Basis of Therapeutics, Seventh Edition, 1985, Alfred G. Gilman et al., editors, pp. 192-201. |
Dexfenfluramine: Effects on Food Intake in Various Animal Models, Neil E. Rowland and Janis Carlton, Clinical Neuropharmacology, vol 11, suppl. 1, pp. S33-S50, 1988. |
Wurtman et al., Science, vol. 198, pp. 1178-1180, Dec., 1977. |
Abstract for “Treatment of Post-Traumatic Stress Syndrome”. |
Abstract for “Metabolic and hormonal effects of dexfenfluramine on stress situations,”. |
Zethof et al., “Stress-induced hyperthermia as a putative anxiety model,” European Journal of Pharmacology, 294 (1995), pp. 125-135. |
Papp et al., “Pharmacological validation of the chornic mild stress model of depression,” European Journal of Pharmacology, 296 (1996), pp. 129-136. |
McKittrick et al., “Serotonin Receptor Binding in a Colony Model of Chronic Social Stress,” Biological Psychiatry, 1995; vol. 37, pp. 383-393. |
Graeff et al., “Role of 5-HT in Stress, Anxiety, and Depression,” Pharmacology Biochemistry and Behavior, (1996) vol. 54, No. 1, pp. 129-141. |
Neal et al., “An open trial of moclobemide in the treatment of post-traumatic stress disorder,” International Clinical Psychopharmacology (1997), vol. 12, pp. 231-237. |
Davidson, “Biological Therapies of Posttraumatic Stress Disorder: An Overview,” J. Clin. Psychiatry, 1997, vol. 58 (supp. 9), pp. 29-32. |
Friedman, “Drug Treatment for PTSD: Answers and Questions,” National Center for PTSD, White River Junction, VT and Depts. of Psychiatry and Pharmacology: Dartmouth Med. School, Hanover, NH, XP-000914298, pp. 359-371. |
Abstract XP-002197787. |
Abstract XP-002197788. |
Abstract XP-002197789. |
Wurtman et al., “Fenfluramine and Fluoxetine Spare Protein Consumption While Suppressing Caloric Intake by Rats,” Science: American Association for the Advancement of Science, Dec. 1977, vol. 198, No. 4322. |
Rowland et al., “Dexfenfluramine: Effects on Food Intake in Various Animal Models,” Clinical Neuropharmacology, vol. 11, Supplement 1, 1988, pp. S33-S50. |
Wurtman et al., “Brain Serotonin, Carbohydrate-Craving, Obesity and Depression,” Journal of Obesity Research, vol. 3, Supp. 4, Nov. 1995, pp. 477S-480S. |
Radloff, “The CES-D Scale: A Self-Report Depression Scale for Research in the General Population,” Applied Psychological Measurement, vol. 1, No. 3 Summer 1997, pp. 385-401. |